Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASM
2851
Avino Silver & Gold Mines
ASM
$1.13B
| $428K | ﹤0.01% |
388,957
-43,018
| -10% | -$43.4K |
|
2852
Mission Produce
AVO
$1.11B
| $427K | ﹤0.01% |
+33,300
| New | +$369K |
|
|
AIOS
2853
AIOS Tech
AIOS
$40.7M
| $427K | ﹤0.01% |
1,333
-622
| -32% | -$130K |
|
2854
Crane NXT
CXT
$3.15B
| $426K | ﹤0.01% |
7,600
-43,900
| -85% | -$2.55M |
|
2855
Biglari Holdings Class B
BH
$1.23B
| $426K | ﹤0.01% |
2,476
+90
| +4% | +$16.4K |
|
|
SGMA
2856
DELISTED
Sigmatron International
SGMA
| $425K | ﹤0.01% |
149,087
+9,200
| +7% | +$33.5K |
|
|
ACCS
2857
ACCESS Newswire
ACCS
$26M
| $423K | ﹤0.01% |
35,438
-2,900
| -8% | -$27.9K |
|
2858
Sanara MedTech
SMTI
$313M
| $423K | ﹤0.01% |
14,000
-100
| -0.7% | -$3.12K |
|
2859
Chefs' Warehouse
CHEF
$4.5B
| $420K | ﹤0.01% |
10,000
-30,549
| -75% | -$1.23M |
|
2860
Minerva Neurosciences
NERV
$202M
| $420K | ﹤0.01% |
157,200
-10,500
| -6% | -$30.5K |
|
|
ATXS
2861
DELISTED
Astria Therapeutics
ATXS
| $419K | ﹤0.01% |
38,061
+15,600
| +69% | +$173K |
|
2862
Alpha Teknova
TKNO
$346M
| $416K | ﹤0.01% |
+86,000
| New | +$317K |
|
2863
Vanguard Industrials ETF
VIS
$8.39B
| $416K | ﹤0.01% |
+1,600
| New | +$392K |
|
2864
Cheesecake Factory
CAKE
$5.35B
| $415K | ﹤0.01% |
+10,245
| New | +$390K |
|
2865
Compass Therapeutics
CMPX
$342M
| $410K | ﹤0.01% |
222,600
+82,000
| +58% | +$102K |
|
2866
CVD Equipment Corp
CVV
$58.2M
| $409K | ﹤0.01% |
123,682
-4,600
| -4% | -$17K |
|
2867
iShares ESG Aware MSCI EM ETF
ESGE
$6.68B
| $408K | ﹤0.01% |
+11,200
| New | +$382K |
|
2868
Smart Sand
SND
$189M
| $408K | ﹤0.01% |
206,900
-63,900
| -24% | -$132K |
|
2869
Prelude Therapeutics
PRLD
$364M
| $408K | ﹤0.01% |
196,900
-9,700
| -5% | -$44.9K |
|
|
LITB
2870
LightInTheBox
LITB
$56.5M
| $407K | ﹤0.01% |
140,933
-2,822
| -2% | -$10.1K |
|
|
LUNA
2871
DELISTED
Luna Innovations Incorporated
LUNA
| $407K | ﹤0.01% |
+173,300
| New | +$443K |
|
2872
Pro-Dex
PDEX
$209M
| $407K | ﹤0.01% |
13,640
+1,400
| +11% | +$30.2K |
|
2873
First Trust Energy AlphaDEX Fund
FXN
$368M
| $407K | ﹤0.01% |
+25,100
| New | +$433K |
|
2874
Arbor Realty Trust
ABR
$965M
| $407K | ﹤0.01% |
+26,140
| New | +$363K |
|
2875
Quince Therapeutics
QNCX
$28.9M
| $406K | ﹤0.01% |
2,613
+193
| +8% | +$27.7K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.